微卡辅助治疗复治老年肺结核病临床疗效观察

目的评价微卡辅助治疗复治老年肺结核的疗效。方法将60例复治老年肺结核病患者随机分为两组,试验组、对照组各30例,两组均用相同抗结核治疗,试验组加用微卡。结果治疗3个月后,试验组痰菌阴转率96.7%,X线病灶吸收好转率为93.3%,空洞闭合率86.3%;与对照组73.7%,73.3和65%相比较,差异有显著性。副作用两组结果相似。结论微卡与化疗药物联合应用可提高复治老年肺结核的疗效,使用安全。

Clinical effects of mycobacterium-vaccae-assisted method in treatment of elderly relapsing tuberculosis patients

Objective To evaluate clinical effects of mycobacterium-vaccae-assisted method in treatment of elderly relapsing tuberculosis patients.Methods A total of 60 elderly relapsing tuberculosis patients were randomly divided into two groups: the treatment group (n=30) who received mycobacterium vaccae plus combined chemotherapy and the control group (n=30) who received combined chemotherapy only. The clinical effects and side effects between the two groups were compared. Results The sputum convention cute rate, the pulmonary tuberculosis lesion absorption rate and the cavity closed rate after 3-month treatment for the treatment group were 96.7%, 93.3%, and 86.3%, respectively, and for the controls the rates were 73.7%, 73.3%, and 65%, respectively. The rates between the two groups were statistically different. However, the side effects between the two groups were similar.Conclusion Use of mycobacterium vaccae combined with chemotherapy may increase clinical effects in treating elderly relapsing tuberculosis patients and it is safe.